Experimental breast cancer vaccine proves safe in phase 1 clinical trials
Excerpt Recent studies on an experimental vaccine for breast cancer under the direction of Dr. Mary (Nora) L. Disis at the University of Washington Medicine Cancer Vaccine Institute have demonstrated that this vaccine induces a potent immune response to the important tumour protein ERBB2, formerly known as HER2. Article Summary In a study published in […]
CanSino Biologics Celebrates the Rollout of the Inhaled Vaccine, Convidecia Air™, in Shanghai
Excerpt Cansino Biologics announced that the Joint Prevention and Control Mechanism of the State Council of China had approved its Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) for Inhalation (trade name: Convidecia AirTM) for inclusion in Shanghai’s booster vaccination programme. This marks the beginning of the rollout of the world’s first inhaled COVID-19 vaccine, Convidecia […]
RVAC Medicines Initiates First-in-Human Clinical Trials for mRNA COVID-19 Vaccine Candidates
Excerpt RVAC Medicines Pte. Ltd., an mRNA technology platform company launched by CBC Group in 2021 announced first-in-human study evaluating the business’s mRNA-based COVID-19 vaccine candidate, RVM-V001 Article Summary RVAC Medicines Pte. Ltd., an mRNA technology platform company launched by CBC Group in 2021 announced first-in-human study evaluating the business’s mRNA-based COVID-19 vaccine candidate, RVM-V001 […]
Indonesia approves first home-grown COVID vaccine for emergency use
Excerpt Indonesia has approved its first domestically-produced COVID-19 vaccine for emergency use for people over 18 Article Summary Indonesia has approved its first domestically-produced COVID-19 vaccine for emergency use for people over 18 The Indovac vaccine has been developed by Indonesia’s state-owned pharmaceutical company Bio Farma and the Texas Children’s Hospital Center for Vaccine Development […]
The US National Institute of Health has awarded a contract worth AU$19 million for a study to create the newest tuberculosis vaccinations to The University of Sydney and The Centenary Institute, together with collaborators
Excerpt The National Institute of Allergy and Infectious Diseases, a division of the US National Institutes of Health (NIH), has given the University of Sydney and The Centenary Institute a contract worth AU$19 million to create the next generation of tuberculosis (TB) vaccines. Article Summary The National Institute of Allergy and Infectious Diseases, a division […]
Vaxxas receives $8.2 million grant to support manufacturing scale-up in its Australian manufacturing facility
Excerpt As part of the Australian Federal Government’s Modern Production Initiative (MMI), Vaxxas will receive a AU$8.2 million second round grant to promote the manufacturing scale-up of their potentially game-changing technology that enables vaccines to be delivered to the skin using a small patch. Article Summary To support the specialised infrastructure required to produce its […]
IAVI announces the beginning of the Phase I clinical trial for a prospective Lassa fever vaccine in Liberia.
Excerpt In a Phase I clinical trial supported by the Coalition for Epidemic Preparedness Innovations, IAVI, a nonprofit scientific research organisation, reports that volunteers at the PREVAIL clinical trial site at Redemption Hospital (RH1) in Monrovia, Liberia, have received vaccinations with IAVI’s novel vaccine candidate against Lassa fever virus (LASV) (CEPI) Article Summary Lassa fever […]
Malaria booster vaccine continues to achieve the 75% efficacy target set by the WHO.
Excerpt Researchers from the University of Oxford and their collaborators discovered that a booster dose of the vaccine administered one year after the initial three-dose regimen maintained high efficacy against malaria and continued to meet the World Health Organization’s goal of a vaccine with at least 75% efficacy. Article Summary Following the administration of a […]
The anti-covid vaccine from Bharat Biotech was authorised for use in an emergency by the Drugs Controller General of India (DCGI). It is the nation’s first such vaccine
Excerpt The anti-covid vaccine from Bharat Biotech was authorised for use in an emergency by the Drugs Controller General of India (DCGI). It is the nation’s first such vaccine. India won’t have to rely solely on the intramuscular injections that were previously provided thanks to this. Article Summary A vaccination can be administered via a […]
Department of Biotechnology announces the scientific completion of India’s first qHPV vaccine ‘CERVAVAC’
Excerpt Department of Biotechnology announces the scientific completion of India’s first qHPV vaccine ‘CERVAVAC’ Article Summary The Hon. Minister of State for Science, Technology, and Earth Sciences, Dr. Jitendra Singh, announced the development of India’s first quadrivalent human papillomavirus vaccine (CERVAVAC) for the prevention of cervical cancer. The Bill and Melinda Gates Foundation collaborated with […]
Moderna signs contract to supply Covid-19 booster vaccines to the US
Excerpt: The initial 66 million vaccine doses are anticipated to be supplied this year. Article Summary: Moderna has entered a new supply contract with the US Government to deliver 66 million doses of its Covid-19 vaccine booster candidate, mRNA-1273.222. The contract comprises a $1.74bn award to produce and supply these vaccine doses and […]
First homegrown COVID-19 vaccination available in Korea
Excerpt SKYCovione is the country’s first homegrown vaccine to have successfully completed all three phases of its clinical trial Article Summary South Korea took a significant step toward establishing vaccine sovereignty in the fight against the pandemic on Wednesday by approving the use of SKYCovione, the nation’s first indigenous COVID-19 vaccine created by SK Bioscience […]
